top of page
News, Events and Updates
Search
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 12, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Improved both Primary Cognitive and Second MDS-UPDRS
Jun 28, 2021
Anavex Life Sciences Reports the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B)
Jun 14, 2021
Anavex Life Sciences Presents Proof of Concept Controlled Phase 2 Clinical Trial Data
Nov 6, 2020
Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Trial
Oct 15, 2020
Anavex Life Sciences Announces Commitment for Financial Investment by Shake It Up Foundation
Aug 19, 2020
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
